ENTITY

Vaxcell-Bio Therapeutics (323990 KS)

6

Analysis

Health Care • South Korea

Vaxcell-Bio Therapeutics, Co. Ltd operates pharmaceutical development businesses. The Company develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines. Vaxcell-Bio Therapeutics conducts businesses in South Korea.

more

Refresh

Exchange Announcement • 20 Nov 2024 16:16

[Revised] Other Management Information(Voluntary Disclosure)(ìê·ëª¨í©ë³ ì¹ì¸ ì´ì¬í ê²°ì(ì£¼ì£¼ì´í ê°ì) ê²°ê³¼ë³´ê³ )

Exchange Announcement • 20 Nov 2024 15:38

Other Management Information(Voluntary Disclosure)(ìê·ëª¨í©ë³ ì¹ì¸ ì´ì¬í ê²°ì(ì£¼ì£¼ì´í ê°ì) ê²°ê³¼ë³´ê³ )

Exchange Announcement • 08 Aug 2024 13:53

Material Management Information related to Judgment of Investment(ì ì ì¢ ìì ì´íë ê°ìì ìì í ì ì©íë íìë³ì©ì¹ë£ì (Vaxleukin-15 inj.) íëª©íê° ì¹ì¸)

Exchange Announcement • 22 May 2024 13:47

Material Management Information related to Judgment of Investment(Study Results)(ì§íì± ê°ì¸í¬ì íììì ìì°ì´í´ì¸í¬ì ê°ëë§¥ì£¼ì ííìë² ë³í©ì¹ë£ì ìì 2aì ì°êµ¬ ê²°ê³¼)

Exchange Announcement • 23 Apr 2024 17:17

Material Management Information related to Judgment of Investment(ì§íì± ì·ì¥ì íììì ìì°ì´í´ì¸í¬ì mFOLFIRINOX ë³í©ì¹ë£ì ìì 2aì ì°êµ¬ ìììíê³í ì ì² ë°ë ¤)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.41.4

x